chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (A booster dose was given today at about 12:15pm from a vial that was first punctured on 20Dec2021 at about 9:40am and that vial was left out at room temperature the entire time) and EXPIRED PRODUCT ADMINISTERED (A booster dose was given today at about 12:15pm from a vial that was first punctured on 20 Dec 2021) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 009C21A) for COVID-19 vaccination. No Medical History information was reported. On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Dec-2021, the patient experienced PRODUCT STORAGE ERROR (A booster dose was given today at about 12:15pm from a vial that was first punctured on 20Dec2021 at about 9:40am and that vial was left out at room temperature the entire time) and EXPIRED PRODUCT ADMINISTERED (A booster dose was given today at about 12:15pm from a vial that was first punctured on 20 Dec 2021). On 21-Dec-2021, PRODUCT STORAGE ERROR (A booster dose was given today at about 12:15pm from a vial that was first punctured on 20Dec2021 at about 9:40am and that vial was left out at room temperature the entire time) and EXPIRED PRODUCT ADMINISTERED (A booster dose was given today at about 12:15pm from a vial that was first punctured on 20 Dec 2021) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant Drug details were reported. No Treatment information was provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Feeling hot, Hypoaesthesia oral, Paraesthesia oral, Urticaria
Clinical narrative: Felt very hot inside her body after first shot; Tongue felt tingling after first shot; Tongue felt numb after first shot; Mild hives on her chest after first shot; Blood Pressure was very high after first shot; The reaction came on & off every 10 minutes after first shot / 10 days later the same reaction  happened randomly for about 5 minutes after first shot; This spontaneous case was reported by a nurse and describes the occurrence of FEELING HOT (Felt very hot inside her body after first shot), PARAESTHESIA ORAL (Tongue felt tingling after first shot), HYPOAESTHESIA ORAL (Tongue felt numb after first shot), URTICARIA (Mild hives on her chest after first shot) and BLOOD PRESSURE INCREASED (Blood Pressure was very high after first shot) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (reaction to Medrol a year prior to COVID-19 vaccination.).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced FEELING HOT (Felt very hot inside her body after first shot), PARAESTHESIA ORAL (Tongue felt tingling after first shot), HYPOAESTHESIA ORAL (Tongue felt numb after first shot), URTICARIA (Mild hives on her chest after first shot), BLOOD PRESSURE INCREASED (Blood Pressure was very high after first shot) and VACCINATION COMPLICATION (The reaction came on & off every 10 minutes after first shot / 10 days later the same reaction  happened randomly for about 5 minutes after first shot). The patient was treated with FAMOTIDINE (PEPCID [FAMOTIDINE]) for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 16-Jan-2021, FEELING HOT (Felt very hot inside her body after first shot), PARAESTHESIA ORAL (Tongue felt tingling after first shot), HYPOAESTHESIA ORAL (Tongue felt numb after first shot), URTICARIA (Mild hives on her chest after first shot), BLOOD PRESSURE INCREASED (Blood Pressure was very high after first shot) and VACCINATION COMPLICATION (The reaction came on & off every 10 minutes after first shot / 10 days later the same reaction  happened randomly for about 5 minutes after first shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Felt very hot inside her body after first shot; Tongue felt tingling after first shot; Tongue felt numb after first shot; Mild hives on her chest after first shot; Blood Pressure was very high after first shot; The reaction came on & off every 10 minutes after first shot / 10 days later the same reaction  happened randomly for about 5 minutes after first shot; This spontaneous case was reported by a nurse and describes the occurrence of FEELING HOT (Felt very hot inside her body after first shot), PARAESTHESIA ORAL (Tongue felt tingling after first shot), HYPOAESTHESIA ORAL (Tongue felt numb after first shot), URTICARIA (Mild hives on her chest after first shot) and BLOOD PRESSURE INCREASED (Blood Pressure was very high after first shot) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (reaction to Medrol a year prior to COVID-19 vaccination.).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced FEELING HOT (Felt very hot inside her body after first shot), PARAESTHESIA ORAL (Tongue felt tingling after first shot), HYPOAESTHESIA ORAL (Tongue felt numb after first shot), URTICARIA (Mild hives on her chest after first shot), BLOOD PRESSURE INCREASED (Blood Pressure was very high after first shot) and VACCINATION COMPLICATION (The reaction came on & off every 10 minutes after first shot / 10 days later the same reaction  happened randomly for about 5 minutes after first shot). The patient was treated with FAMOTIDINE (PEPCID [FAMOTIDINE]) for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 16-Jan-2021, FEELING HOT (Felt very hot inside her body after first shot), PARAESTHESIA ORAL (Tongue felt tingling after first shot), HYPOAESTHESIA ORAL (Tongue felt numb after first shot), URTICARIA (Mild hives on her chest after first shot), BLOOD PRESSURE INCREASED (Blood Pressure was very high after first shot) and VACCINATION COMPLICATION (The reaction came on & off every 10 minutes after first shot / 10 days later the same reaction  happened randomly for about 5 minutes after first shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Histamine intolerance, Palpitations, Somnolence
Clinical narrative: heart racing; sleeping a lot; histamine intolerance/histamine intolerance got exponentially worse; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart racing), SOMNOLENCE (sleeping a lot), HISTAMINE INTOLERANCE (histamine intolerance/histamine intolerance got exponentially worse) and FATIGUE (Tired) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032H21A, 045B21A and 037A21B) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (heart racing), SOMNOLENCE (sleeping a lot), HISTAMINE INTOLERANCE (histamine intolerance/histamine intolerance got exponentially worse) and FATIGUE (Tired). At the time of the report, PALPITATIONS (heart racing), SOMNOLENCE (sleeping a lot) and FATIGUE (Tired) outcome was unknown and HISTAMINE INTOLERANCE (histamine intolerance/histamine intolerance got exponentially worse) had not resolved.            The treatment information were Detox through doctor's care. Two supplements (DAO digestive enzyme and Aller DHQ)   This case was linked to MOD-2021-421477 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered booster doses  stored in the refrigerator on 16Nov2021 (beyond the 30 use by date)) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H21B, 032L20A and 032M20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Dec-2021 at 3:15 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (administered booster doses  stored in the refrigerator on 16Nov2021 (beyond the 30 use by date)). On 16-Dec-2021, EXPIRED PRODUCT ADMINISTERED (administered booster doses  stored in the refrigerator on 16Nov2021 (beyond the 30 use by date)) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant & treatment drug reported. Patient partial DOB reported-  02Ju1945.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: A provider used the vaccine after it was opened for 5 days; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED. At the time of the report, EXPIRED PRODUCT ADMINISTERED had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment information was not reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Expired product administered, Fatigue, Malaise
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE, MALAISE, PAIN, VACCINATION SITE MOVEMENT IMPAIRMENT, and VACCINATION SITE SWELLING in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication JANSSEN COVID-19 VACCINE (Primary dose). Past adverse reactions to the above products included No adverse reaction with JANSSEN COVID-19 VACCINE.    On 18-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 19-Dec-2021, the patient experienced SOMNOLENCE, MALAISE, PAIN, VACCINATION SITE MOVEMENT IMPAIRMENT, VACCINATION SITE SWELLING, VACCINATION SITE PAIN, CHILLS, FATIGUE, and PYREXIA. On 18-Dec-2021, EXPIRED PRODUCT ADMINISTERED had resolved. At the time of the report, SOMNOLENCE, MALAISE, PAIN, VACCINATION SITE MOVEMENT IMPAIRMENT, VACCINATION SITE SWELLING, VACCINATION SITE PAIN, CHILLS, and FATIGUE had not resolved and PYREXIA had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available) on 19-Dec-2021, Body temperature 101-102.6 (High).         No concomitant medications were provided by reporter. No treatment medications were reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Somnolence, Vaccination site movement impairment, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE, MALAISE, PAIN, VACCINATION SITE MOVEMENT IMPAIRMENT, and VACCINATION SITE SWELLING in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication JANSSEN COVID-19 VACCINE (Primary dose). Past adverse reactions to the above products included No adverse reaction with JANSSEN COVID-19 VACCINE.    On 18-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 19-Dec-2021, the patient experienced SOMNOLENCE, MALAISE, PAIN, VACCINATION SITE MOVEMENT IMPAIRMENT, VACCINATION SITE SWELLING, VACCINATION SITE PAIN, CHILLS, FATIGUE, and PYREXIA. On 18-Dec-2021, EXPIRED PRODUCT ADMINISTERED had resolved. At the time of the report, SOMNOLENCE, MALAISE, PAIN, VACCINATION SITE MOVEMENT IMPAIRMENT, VACCINATION SITE SWELLING, VACCINATION SITE PAIN, CHILLS, and FATIGUE had not resolved and PYREXIA had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available) on 19-Dec-2021, Body temperature 101-102.6 (High).         No concomitant medications were provided by reporter. No treatment medications were reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE, MALAISE, PAIN, VACCINATION SITE MOVEMENT IMPAIRMENT, and VACCINATION SITE SWELLING in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication JANSSEN COVID-19 VACCINE (Primary dose). Past adverse reactions to the above products included No adverse reaction with JANSSEN COVID-19 VACCINE.    On 18-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 19-Dec-2021, the patient experienced SOMNOLENCE, MALAISE, PAIN, VACCINATION SITE MOVEMENT IMPAIRMENT, VACCINATION SITE SWELLING, VACCINATION SITE PAIN, CHILLS, FATIGUE, and PYREXIA. On 18-Dec-2021, EXPIRED PRODUCT ADMINISTERED had resolved. At the time of the report, SOMNOLENCE, MALAISE, PAIN, VACCINATION SITE MOVEMENT IMPAIRMENT, VACCINATION SITE SWELLING, VACCINATION SITE PAIN, CHILLS, and FATIGUE had not resolved and PYREXIA had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available) on 19-Dec-2021, Body temperature 101-102.6 (High).         No concomitant medications were provided by reporter. No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Tremor
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), TREMOR (Shaky) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 20-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Dec-2021, the patient experienced TREMOR (Shaky) and CHILLS (Chills). On an unknown date, the patient experienced PAIN (Soreness). At the time of the report, PAIN (Soreness), TREMOR (Shaky) and CHILLS (Chills) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Lymphadenopathy, Magnetic resonance imaging, X-ray
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (bilateral super clavicular swollen lymph nodes) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 immunisation. No Medical History information was reported. On 29-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, the patient experienced LYMPHADENOPATHY (bilateral super clavicular swollen lymph nodes). At the time of the report, LYMPHADENOPATHY (bilateral super clavicular swollen lymph nodes) had not resolved.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood test: normal CBC once & to test for cat scratch fever and normal (normal) toxoplasmosis. In 2021, Magnetic resonance imaging: normal (normal) Normal(with color contrast). In 2021, X-ray: normal (normal) Normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication reported. No treatment information was provided.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Infection, Vaccination site discharge, Vaccination site mass
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCHARGE (oozing with pus and he thinks it was a major infection), INFECTION (oozing with pus and he thinks it was a major infection) and VACCINATION SITE MASS (large lump at the vaccination site) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 030A21A) for COVID-19 vaccination.  No Medical history was reported. Concurrent medical conditions included Gouty arthritis. Concomitant products included PREDNISONE for Gouty arthritis. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced VACCINATION SITE DISCHARGE (oozing with pus and he thinks it was a major infection), INFECTION (oozing with pus and he thinks it was a major infection) and VACCINATION SITE MASS (large lump at the vaccination site). At the time of the report, VACCINATION SITE DISCHARGE (oozing with pus and he thinks it was a major infection), INFECTION (oozing with pus and he thinks it was a major infection) and VACCINATION SITE MASS (large lump at the vaccination site) had resolved. Patient stated that about a week or so after he got the vaccine, while he was taking a shower, he noted a large lump at the vaccination site. He went to see a doctor at an Urgent Care and he was prescribed with a local antibiotic and an antibiotic pill. They drew a circle around the lump and he was advised to keep a close eye on it which he said made it sound severe. It was oozing with pus and he thinks it was a major infection. It resolved in a week or two. Patient stated that he was prescribed with a local antibiotic and an antibiotic pill as a treatment.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effects after two months of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects after two months of the vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects after two months of the vaccine). At the time of the report, VACCINATION COMPLICATION (Side effects after two months of the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment medications were reported
Sex: U
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: seizure after vaccine; This case was received via an unknown source on 24-May-2021 and was forwarded to Moderna on 21-Dec-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SEIZURE. At the time of the report, SEIZURE outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       No concomitant medication was provided. No Treatment medication was provided.  This is a spontaneous case concerns a patient of unknown age and gender with no reported medical history, who experienced the unexpected, non-serious and AESI of Seizure. Time to onset from vaccination with mRNA-1273 vaccine was not reported. Vaccination date or dose number were not reported. It is not clear by narrative if there is a patient that experienced the adverse event or not. The rechallenge is not applicable. The benefit -risk relationship of mRNA -1273 Vaccine is not affected by this report.   Reporter did not allow further contact. This is a spontaneous case concerns a patient of unknown age and gender with no reported medical history, who experienced the unexpected, non-serious and AESI of Seizure. Time to onset from vaccination with mRNA-1273 vaccine was not reported. Vaccination date or dose number were not reported. It is not clear by narrative if there is a patient that experienced the adverse event or not. The rechallenge is not applicable. The benefit -risk relationship of mRNA -1273 Vaccine is not affected by this report.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling cold, Mobility decreased, Nervousness, Tremor
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of TREMOR, NERVOUSNESS, MOBILITY DECREASED, and FEELING COLD (head to toe felt cold) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011F21A, 044A21A, and 022M20A) for COVID-19 vaccination.     Concomitant products included TERAZOSIN for an unknown indication.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced TREMOR, NERVOUSNESS, MOBILITY DECREASED, and FEELING COLD. In November 2021, FEELING COLD had resolved. At the time of the report, TREMOR, NERVOUSNESS, and MOBILITY DECREASED outcome was unknown.            Treatment medication include Advil or Ibuprofen  Patient reports after the booster shot on the first night the patient from head to toe felt cold, shaking and they eventually went away. Patient reports on the second night the patient was trembling from head to toe, like in a ice cold water for a long time but he wasn't actually cold and it lasted from head to toes, whole body trembled, very nerving, couldn't function, laid in bed shaking for a few hours. Patient talked to an HCP over the phone and they told him to take some Advil or Ibuprofen so he did. Patient reports that the nurse asked him to stay there after the shot for about 10 minutes and didn't tell anyone else so the patient was not sure if they gave him the full dose or not.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Hot flush, Lymphadenopathy, Menopausal disorder
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (It is still red), PALPITATIONS (Heart palpitations, (described as a heartbeat little bit faster)/I could hear it pumping), ORAL HERPES (2 humongous cold sores), VACCINATION SITE WARMTH (On the injection site, it was heated and hot) and MENOPAUSAL DISORDER (Worse one was this shot reactivated my menopause) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B81A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced HOT FLUSH (Had hot flashes from April 2021 to Nov 2021, It was terrible). On an unknown date, the patient experienced ERYTHEMA (It is still red), PALPITATIONS (Heart palpitations, (described as a heartbeat little bit faster)/I could hear it pumping), ORAL HERPES (2 humongous cold sores), VACCINATION SITE WARMTH (On the injection site, it was heated and hot), MENOPAUSAL DISORDER (Worse one was this shot reactivated my menopause), SCAR (One left a scar, they were the size of a nickel), HEADACHE (Low/dim headache for 2-3 weeks), LYMPHADENOPATHY (Really swollen lymph node under the center of my it was really swollen) and VACCINATION SITE ERYTHEMA (Injection site, it was red). In November 2021, HOT FLUSH (Had hot flashes from April 2021 to Nov 2021, It was terrible) had resolved. At the time of the report, ERYTHEMA (It is still red) had not resolved, PALPITATIONS (Heart palpitations, (described as a heartbeat little bit faster)/I could hear it pumping), ORAL HERPES (2 humongous cold sores), VACCINATION SITE WARMTH (On the injection site, it was heated and hot), MENOPAUSAL DISORDER (Worse one was this shot reactivated my menopause), SCAR (One left a scar, they were the size of a nickel), LYMPHADENOPATHY (Really swollen lymph node under the center of my it was really swollen) and VACCINATION SITE ERYTHEMA (Injection site, it was red) outcome was unknown and HEADACHE (Low/dim headache for 2-3 weeks) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were reported.  Patient have no history of heart issues.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes, Palpitations, Scar, Vaccination site erythema, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (It is still red), PALPITATIONS (Heart palpitations, (described as a heartbeat little bit faster)/I could hear it pumping), ORAL HERPES (2 humongous cold sores), VACCINATION SITE WARMTH (On the injection site, it was heated and hot) and MENOPAUSAL DISORDER (Worse one was this shot reactivated my menopause) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B81A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced HOT FLUSH (Had hot flashes from April 2021 to Nov 2021, It was terrible). On an unknown date, the patient experienced ERYTHEMA (It is still red), PALPITATIONS (Heart palpitations, (described as a heartbeat little bit faster)/I could hear it pumping), ORAL HERPES (2 humongous cold sores), VACCINATION SITE WARMTH (On the injection site, it was heated and hot), MENOPAUSAL DISORDER (Worse one was this shot reactivated my menopause), SCAR (One left a scar, they were the size of a nickel), HEADACHE (Low/dim headache for 2-3 weeks), LYMPHADENOPATHY (Really swollen lymph node under the center of my it was really swollen) and VACCINATION SITE ERYTHEMA (Injection site, it was red). In November 2021, HOT FLUSH (Had hot flashes from April 2021 to Nov 2021, It was terrible) had resolved. At the time of the report, ERYTHEMA (It is still red) had not resolved, PALPITATIONS (Heart palpitations, (described as a heartbeat little bit faster)/I could hear it pumping), ORAL HERPES (2 humongous cold sores), VACCINATION SITE WARMTH (On the injection site, it was heated and hot), MENOPAUSAL DISORDER (Worse one was this shot reactivated my menopause), SCAR (One left a scar, they were the size of a nickel), LYMPHADENOPATHY (Really swollen lymph node under the center of my it was really swollen) and VACCINATION SITE ERYTHEMA (Injection site, it was red) outcome was unknown and HEADACHE (Low/dim headache for 2-3 weeks) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were reported.  Patient have no history of heart issues.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain under arm) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012H21B, 010M20A and 026M12A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Dec-2021, the patient experienced PAIN IN EXTREMITY (pain under arm). At the time of the report, PAIN IN EXTREMITY (pain under arm) had not resolved.    Caller reports no pre-existing condition and no allergy. No relevant concomitant medications were provided. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Tremor
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking problemsv / a twik) and CONFUSIONAL STATE (Confused) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (Shaking problemsv / a twik) and CONFUSIONAL STATE (Confused). At the time of the report, TREMOR (Shaking problemsv / a twik) and CONFUSIONAL STATE (Confused) outcome was unknown.            No concomitant medication provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: Achy; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy) and HEADACHE (Headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045121A, 003A21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Achy) and HEADACHE (Headaches). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (Achy) and HEADACHE (Headaches) outcome was unknown.            No Concomitant medication was reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (accidently gave patient the Moderna booster instead of a flu shot) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Previously administered products included for COVID-19 vaccination: COVID-19 Vaccine (Patient received two Pfizer vaccines. Patient also received a Pfizer booster on 04OCT2021.) on 04-Oct-2021. Past adverse reactions to the above products included No adverse event with COVID-19 Vaccine. On 21-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Dec-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (accidently gave patient the Moderna booster instead of a flu shot). On 21-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (accidently gave patient the Moderna booster instead of a flu shot) had resolved. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness
Clinical narrative: light flu like symptoms; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (light flu like symptoms) and FATIGUE (fatigue) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Janssen COVID-19 vaccine on 14-Mar-2021. Past adverse reactions to the above products included No adverse event with Janssen COVID-19 vaccine. Concurrent medical conditions included Lymphoma (treated in the past. She is currently in remission and is not going through any treatments) and Shingles (Patient put on Valcyclovir.) since May 2021. Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALCYVIR) for Shingles, MULTIVITAMIN [VITAMINS NOS] and VITAMIN D NOS for an unknown indication. On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Aug-2021, the patient experienced INFLUENZA LIKE ILLNESS (light flu like symptoms) and FATIGUE (fatigue). On 13-Aug-2021, INFLUENZA LIKE ILLNESS (light flu like symptoms) and FATIGUE (fatigue) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment drugs were reported. This case was linked to MOD-2021-418874 (Patient Link).
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was a little more sore than the first two Moderna shots; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little more sore than the first two Moderna shots) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Peripheral arterial disease.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was a little more sore than the first two Moderna shots). At the time of the report, PAIN IN EXTREMITY (arm was a little more sore than the first two Moderna shots) outcome was unknown.            No concomitant medications were not reported.  Treatment medications were not provided by the reporter.   This case was linked to MOD-2021-419807, MOD-2021-005696 (Patient Link).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 10-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment information was provided.   This case was linked to MOD-2021-418891 (Patient Link).
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: receiving booster dose from an expired vial; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041c21a, 017821a, and 036a21a) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 12-Dec-2021, EXPIRED PRODUCT ADMINISTERED had resolved.            No concomitant medications was provided. No treatment medications was provided.   Most recent FOLLOW-UP information incorporated above includes on 22-Dec-2021 Follow up received.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Illness, Myalgia, Night sweats
Clinical narrative: she has a hard time breathing; woke up all wet; has been sick for 4 days; She has a hard time walking because of the hip pain; She also reports muscle pain, aches; She ran a fever; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (she has a hard time breathing), NIGHT SWEATS (woke up all wet), ILLNESS (has been sick for 4 days), ARTHRALGIA (She has a hard time walking because of the hip pain) and MYALGIA (She also reports muscle pain, aches) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes (She has diabetes) and Arthritis (She have bad arthritis from before).    On 16-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced DYSPNOEA (she has a hard time breathing), NIGHT SWEATS (woke up all wet), ILLNESS (has been sick for 4 days), ARTHRALGIA (She has a hard time walking because of the hip pain), MYALGIA (She also reports muscle pain, aches), PYREXIA (She ran a fever) and VOMITING (vomiting). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at a dose of 3 times a day. In December 2021, ILLNESS (has been sick for 4 days) had resolved. At the time of the report, DYSPNOEA (she has a hard time breathing), NIGHT SWEATS (woke up all wet), ARTHRALGIA (She has a hard time walking because of the hip pain), MYALGIA (She also reports muscle pain, aches), PYREXIA (She ran a fever) and VOMITING (vomiting) had not resolved.            She takes a lot of medications, but did not specify which ones. She received a full dose of the vaccine for her third dose because she has diabetes, and they said she needs a third dose. She got better, then worse.  She is still experiencing symptoms.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: she has a hard time breathing; woke up all wet; has been sick for 4 days; She has a hard time walking because of the hip pain; She also reports muscle pain, aches; She ran a fever; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (she has a hard time breathing), NIGHT SWEATS (woke up all wet), ILLNESS (has been sick for 4 days), ARTHRALGIA (She has a hard time walking because of the hip pain) and MYALGIA (She also reports muscle pain, aches) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes (She has diabetes) and Arthritis (She have bad arthritis from before).    On 16-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced DYSPNOEA (she has a hard time breathing), NIGHT SWEATS (woke up all wet), ILLNESS (has been sick for 4 days), ARTHRALGIA (She has a hard time walking because of the hip pain), MYALGIA (She also reports muscle pain, aches), PYREXIA (She ran a fever) and VOMITING (vomiting). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at a dose of 3 times a day. In December 2021, ILLNESS (has been sick for 4 days) had resolved. At the time of the report, DYSPNOEA (she has a hard time breathing), NIGHT SWEATS (woke up all wet), ARTHRALGIA (She has a hard time walking because of the hip pain), MYALGIA (She also reports muscle pain, aches), PYREXIA (She ran a fever) and VOMITING (vomiting) had not resolved.            She takes a lot of medications, but did not specify which ones. She received a full dose of the vaccine for her third dose because she has diabetes, and they said she needs a third dose. She got better, then worse.  She is still experiencing symptoms.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 10-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was reported.   This case was linked to MOD-2021-418891 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication provided. No treatment information provided.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received expired dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired dose) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired dose). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-418891 (Patient Link).
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment medications were reported   This case was linked to MOD-2021-418891 (Patient Link).